EUDA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
EUDA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EUDA Health Holdings's change in receivables for the quarter that ended in Jun. 2023 was $0.00 Mil. It means EUDA Health Holdings's Accounts Receivable stayed the same from Mar. 2023 to Jun. 2023 .
EUDA Health Holdings's change in receivables for the fiscal year that ended in Dec. 2023 was $-0.03 Mil. It means EUDA Health Holdings's Accounts Receivable increased by $0.03 Mil from Dec. 2022 to Dec. 2023 .
EUDA Health Holdings's Accounts Receivable for the quarter that ended in Jun. 2023 was $0.88 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. EUDA Health Holdings's Days Sales Outstanding for the three months ended in Jun. 2023 was 72.54.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. EUDA Health Holdings's liquidation value for the three months ended in Jun. 2023 was $-7.07 Mil.
The historical data trend for EUDA Health Holdings's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EUDA Health Holdings Annual Data | |||||||||
Trend | Dec20 | Dec21 | Dec22 | Dec23 | |||||
Change In Receivables | -0.14 | -0.09 | 1.73 | -0.03 |
EUDA Health Holdings Quarterly Data | ||||||||||
Dec20 | Jun21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Dec23 | |
Change In Receivables | Get a 7-Day Free Trial | 0.34 | - | 0.24 | - | - |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.58 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EUDA Health Holdings (NAS:EUDA) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
EUDA Health Holdings's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 0.88 | / | 1.107 | * | 91 |
= | 72.54 |
2. In Ben Graham's calculation of liquidation value, EUDA Health Holdings's accounts receivable are only considered to be worth 75% of book value:
EUDA Health Holdings's liquidation value for the quarter that ended in Jun. 2023 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 0.32 | - | 8.054 | + | 0.75 * 0.88 | + | 0.5 * 0 |
= | -7.07 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of EUDA Health Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Kongyew Wong | director | C/O 6 EU TONG SEN STREET, #08-13, THE CENTRAL U0 059817 |
Chen Wei Wen Kelvin | director, officer: CHIEF EXECUTIVE OFFICER | C/O 1 PEMIMPIN DRIVE #12-07,, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151 |
Alfred Lim | director | C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPI, SINGAPORE U0 576151 |
Kim Hing Chan | director | C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151 |
David Francis Capes | director | C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151 |
Daniel Tan | officer: CHIEF TECHNOLOGY OFFICER | C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151 |
Steven John Sobak | officer: CHIEF FINANCIAL OFFICER | C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151 |
Lim Thien Su Gerald | director | C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPI, SINGAPORE U0 576151 |
Tan Meng Dong (james) | director, 10 percent owner, officer: Chief Executive Officer | UNIT 2003 KINGKEY 100, TOWER B, 5015 SHENNAN EAST ROAD, LUOHU DISTRICT, SHENZHEN/GUANGDONG F4 518000 |
Alexander K. Arrow | director | PO BOX 3094, REDWOOD CITY CA 94064 |
Kwong Yeow Liew | director | RM 2313-2315, BLOCK B, ZHONGSHEN GARDEN, SHENZHEN F4 518101 |
Yap Guan Hong William | director, officer: Chief Financial Officer | 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817 |
Ajay Rajpal | director | 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817 |
8i Holdings 2 Pte Ltd | 10 percent owner | C/O 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817 |
From GuruFocus
By Marketwired • 08-04-2023
By GlobeNewswire • 01-16-2024
By Marketwired • 10-05-2023
By Marketwired • 08-14-2023
By PRNewswire PRNewswire • 05-19-2023
By Marketwired • 09-22-2023
By Value_Insider Value_Insider • 11-23-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.